FDA announces Class 1 recalls for patient return electrodes, intra-aortic balloon catheters, anesthesia systems
Editor's Note The US Food & Drug Administration (FDA) has announced Class 1 recalls—the most severe category, indicating risk of serious injury or death—for three products: MEGA SOFT Pediatric Patient Return Electrodes from Megadyne, Vaporizer Sevoflurane Maquet Filling from Getinge; and Arrow FiberOptix Intra-Aortic Balloon Catheter Kit and Arrow UltraFlex…
Study: standard preoperative fasting guidelines safe for GLP-1 patients
Editor's Note Preoperative use of GLP-1 receptor agonists (RA) medications such as Ozempic and Wegovy is safe, according to a study published in the June issue of the American Journal of Gastroenterology. Controversy has swirled around these drugs due to the risk of slowed stomach emptying increasing a patient’s odds…
Carbon-conscious health systems phase out desflurane anesthesia gas to reduce emissions
Editor's Note Citing environmental concerns, multiple health systems have stopped using desflurane anesthesia gas, Becker’s Hospital Review reported on May 7. Citing the Philadelphia Inquirer, the outlet notes that Children's Hospital of Philadelphia and Marlton, N.J.-based Virtua Health are among those that have eliminated the gas so far, with the…
Study: Surgical team diversity improves patient outcomes
Editor's Note The more diverse the surgical team, the better the outcomes for patients and the lower the cost of care, according to a study of more than 700,000 operations at 88 hospitals in Ontario, Canada. Published May 15 in the British Journal of Surgery, findings show that surgeon-anesthetist teams…
Data cast doubt on recommendation to delay weight-loss meds prior to surgery
Editor's Note A recent analysis of insurance claims data suggests weight-loss medications like Ozempic (semaglutide), Trulicity (dulaglutide), and other glucagon-like peptide-1 (GLP-1) receptor agonists do not increase risks associated with undergoing anesthesia. As reported April 22 in MedPage Today, these finding that contradicts a June 2023 recommendation from the American Society of…
FDA announces class 1 recalls for infusion pumps, anesthesia workstation
Editor's Note Reports of spontaneous backup battery failure in Dreager Inc.’s Perseus A500 anesthesia workstation and multiple failures in InfuTronix, LLC’s Nimbus infusion pump systems prompted the FDA to classify manufacturer recalls as class 1, the most serious categorization indicating risk of serious harm or death. According to an April…
Penn Medicine anesthesia, waste initiatives boost OR sustainability
Editor's Note Penn Medicine has made significant strides in reducing the environmental footprint of the OR through department- and team-level initiatives, according to a March 29 report in Penn Medicine news. Driven by CIRCE: Medicine, a faculty group consisting of providers from Penn Medicine and Children’s Hospital of Philadelphia, examples…
Propofol anesthesia for colonoscopy could help find polyps, prevent cancer
Editor's Note By putting the patient into deeper sedation during colonoscopy, propofol could help doctors find difficult-to-spot, potentially cancerous “serrated” polyps, according to a study published April 17 in Anesthesiology. As an alternative to moderate, “conscious” sedation, propofol facilitates a more thorough exam that is more likely to identify serrated…
Anesthesiologists push to improve pain control during caesarean delivery
Editor's Note A letter to the editor published April 10 in Anesthesiology, the official publication of the American Society of Anesthesiologists (ASA), calls attention to an official statement outlining best practices for ensuring all moms-to-be receive adequate pain management during planned or unexpected C-sections. The best practices are outlined in…
Study: Propofol sedation increases colonoscopy costs without improving outcomes
Editor's Note Although the use of propofol for colonoscopy has been rising due to beliefs that deep sedation leads to greater patient comfort, a recent systematic review and meta-analysis of nearly 1,500 patients from nine randomized controlled trials shows this view is not supported by available evidence. Published March 8…
Free Daily News
- HIPAA security standard update sparks debate over cost, feasibility, patient safety
- Wildfire smoke poses long-term health threats
- Health data inaccuracies cost millions, threaten care quality
- Healthcare employment up in December
- Hospital M&A trends report reveals financial distress, market reorganization
- Study: Patient care experience declined after private equity hospital acquisitions
- Report: Medical student distress rises amid overall healthcare burnout improvement
- Prosthetic insurance coverage disparities persist despite legal protections
- Study: GLP-1 drugs reduce surgical complications in diabetes patients
- United Surgical Partners agrees to $1.48M settlement in 401(k) fee lawsuit